close

Webinar No.005


大師講堂



報告題目


Targeting the adipose vasculature for treatment of metabolic disease

主講人


Professor Yihai Cao

Karolinska Institutet, Sweden


時間


2022年9月2日17:00

(北京時間)

參會方式





掃描右側二維碼

或通過下方鏈接

進入會議直播

https://www.koushare.com/lives/room/421884


主辦單位


Exploration期刊





專家簡介


Yihai Cao is a professor at the Karolinska Institutet, Stockholm, Sweden. He is a member of Chinese Academy of Engineering, Academy of Europe, European Academy of Sciences and Arts, National Academy of Inventors (US), and American Institute of Medicine and Biological Engineering. Yihai Cao received his medical training from the Shandong Medical School and his Ph.D. from the Karolinska Institute. He received his postdoctoral training in Dr. Judah Folkman’s laboratory at the Harvard Medical School. Cao’s laboratory has focused their interests on studying angiogenesis in tumor growth, metastasis, and non-malignant diseases. Through mechanistic studies, he aims to define novel therapeutic targets and resolve clinically unmet demands of antiangiogenic cancer therapy by proposing new concepts and paradigms. His research interests include molecular mechanisms of pathological angiogenesis contributing to obesity, metabolic diseases, diabetic complications, cancer, metastasis, and cardiovascular diseases, with emphasis on clinical relevance and translational research. He received an honorary medical doctor degree (M.D.) from Copenhagen University, Denmark in 2006. He is a guest professor at the Linköping University, Sweden; a guest professor at the Leicester University, UK; an honorary professor at the Copenhagen University, Denmark; and an honorary a professorship at the Shinshu University Japan. He received the Fernström research prize in 2004. He also received the Axel Hirsch Prize in medicine 2014. In 2010, Dr. Cao received a distinguished professor award at the Karolinska Institutet. He was ranked as an outstanding scientist by international experts during the Karolinska Institutet quality assessment in 2010. Dr. Cao received an ERC-advanced research grant award and the distinguished NOVO Nordisk-advanced grant award. His scientific articles have been cited for more than 42 900 times, h-index = 106.



END



期刊簡介


掃描二維碼 | 關注期刊

Exploration由河南大學、中國生物物理學會納米生物學分會主辦,Wiley出版集團出版發行,由梁興傑研究員任主編,師冰洋教授任執行主編。期刊重點發表與推廣打破傳統學科界限的交叉學科領域的最新研究成果及前沿進展,旨在打造具有中國特色,立足國內、面向全球的頂級綜合性國際學術期刊。期刊目前有75位編委會成員,來自11個國家和地區。其中包括兩院院士12位,2021年度全球「高被引科學家」28位,2021「中國高被引學者」21位。
Exploration將堅持以創新水平和科學價值為選稿用稿的唯一標準。期刊當前接受的稿件類型有:研究論文、通訊文章、綜述文章、觀點性文章、評論性文章等。所收投稿將經過嚴格、快速的同行評審,由來自於不同國家和地區的高水平科學家領銜把關,並由經驗豐富的編輯團隊把控稿件處理的整個流程。稿件一經接收將會儘快在線發布。
作為一本開放獲取期刊,Exploration創刊前三年(2021-2023)所接收的文章均無需繳納文章出版費(Article Publication Charges)。

期刊官網1:

https://www.exploration-journals.com/

期刊官網2:

http://www.wileyonlinelibrary.com/journal/exploration

投稿系統:

https://mc.manuscriptcentral.com/exploration


Exploration///



WILEY



MaterialsViews

Wiley旗下材料科學類期刊官方微信平台


關注公眾號和視頻號

推送材料科研資訊|訪談材料大咖新秀

分享撰稿投稿經驗|關注最新招聘信息


點擊「分享」,給我們一點鼓勵吧~


arrow
arrow
    全站熱搜
    創作者介紹
    創作者 鑽石舞台 的頭像
    鑽石舞台

    鑽石舞台

    鑽石舞台 發表在 痞客邦 留言(0) 人氣()